Patents by Inventor Eiji Nara

Eiji Nara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7960416
    Abstract: An emulsion composition comprising (1) a compound (I) represented by the formula (I) wherein each symbol is as defined in the specification (2) an anionic synthetic phospholipid in a proportion of about 0.0001 about 5% (W/V) relative to the composition in total, and (3) a naturally-occurring phospholipid in a proportion of about 0.1 about 10% (W/V) relative to the composition in total is provided.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: June 14, 2011
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Jun Sato, Hikaru Taira, Eiji Nara, Harold Jack Stevens
  • Publication number: 20040253276
    Abstract: An emulsion composition comprising (1) a compound (I) represented by the formula (I) wherein each symbol is as defined in the specification (2) an anionic synthetic phospholipid in a proportion of about 0.0001 about 5% (W/V) relative to the composition in total, and (3) a naturally-occurring phospholipid in a proportion of about 0.1 about 10% (W/V) relative to the composition in total is provided.
    Type: Application
    Filed: August 5, 2004
    Publication date: December 16, 2004
    Inventors: Jun Sato, Hikaru Taira, Eiji Nara, Harold Jack Stevens
  • Publication number: 20040053972
    Abstract: An HER2 inhibitor having an average particle size of about 3 &mgr;m or less or a composition containing the same which has improved HER2 inhibitor-absorbability.
    Type: Application
    Filed: June 4, 2003
    Publication date: March 18, 2004
    Inventor: Eiji Nara
  • Patent number: 6245351
    Abstract: A controlled-release composition comprising a drug-containing core coated with a coating composition containing a water-insoluble substance and a swellable polymer having no basic groups which is capable of maintaining an almost constant drug concentration in plasma over an extended period of time to ensure sustained drug action in the body.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: June 12, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Nara, Yohko Akiyama, Kenji Nakamura